According to Stratview Research, the HPV vaccines market was estimated at USD 6.51 billion in 2022 and is likely to grow at a CAGR of 16.05% during 2023-2028 to reach USD 15.94 billion in 2028.
In the realm of infectious diseases, few threats are as silent and insidious as the Human Papillomavirus (HPV). Silent in its often asymptomatic nature, yet a potent...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian